1.
|
SW LeeY ParkT SoBS KwonH CheroutreRS
MittlerM CroftIdentification of regulatory functions for 4-1BB and
4-1BBL in myelopoiesis and the development of dendritic cellsNat
Immunol9917926200818604213
|
2.
|
C Reis e SousaDendritic cells in a mature
ageNat Rev Immunol6476483200616691244
|
3.
|
AK Thomas-KaskelH VeelkenActive
immunotherapy of prostate cancer with a focus on dendritic
cellsActas Urol Esp31668679200717896564
|
4.
|
J BanchereauAK PaluckaDendritic cells as
therapeutic vaccines against cancerNat Rev
Immunol5296306200515803149
|
5.
|
JS YuG LiuH YingWH YongKL BlackCJ
WheelerVaccination with tumor lysate-pulsed dendritic cells elicits
antigen-specific, cytotoxic T-cells in patients with malignant
gliomaCancer
Res6449734979200410.1158/0008-5472.CAN-03-350515256471
|
6.
|
T ChanA SamiA El-GayedX GuoJ XiangHER-2/
neu-gene engineered dendritic cell vaccine stimulates stronger
HER-2/neu-specific immune responses compared to DNA vaccinationGene
Ther1313911402200610.1038/sj.gt.330279716724093
|
7.
|
E HuarteJR Cubillos-RuizYC NesbethUK
ScarlettDG MartinezRJ BuckanovichF BenenciaRV StanT KelerP SarobeCL
SentmanJR Conejo-GarciaDepletion of dendritic cells delays ovarian
cancer progression by boosting antitumor immunityCancer
Res6876767684200818768667
|
8.
|
JE Moyron-QuirozJ Rangel-MorenoL HartsonK
KusserMP TigheKD KlonowskiL LefrançoisLS CauleyAG HarmsenFE LundTD
RandallPersistence and responsiveness of immunologic memory in the
absence of secondary lymphoid
organsImmunity25643654200617045819
|
9.
|
GK KoskiPA CohenRE RosesS XuBJ
CzernieckiReengineering dendritic cell-based anti-cancer
vaccinesImmunol Rev222256276200818364007
|
10.
|
KR JordanRH McMahanCB KemmlerJW KapplerJE
SlanskyPeptide vaccines prevent tumor growth by activating T cells
that respond to native tumor antigensProc Natl Acad Sci
USA10747884789201020133772
|
11.
|
P KrauseM BrucknerC UermösiE SingerM
GroettrupDF LeglerProstaglandin E(2) enhances T-cell proliferation
by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on
dendritic
cellsBlood11324512460200910.1182/blood-2008-05-15712319029446
|
12.
|
KH YiH NechushtanWJ BowersGR WalkerY
ZhangDG PhamER PodackHJ FederoffKA TolbaJD RosenblattAdoptively
transferred tumor-specific T cells stimulated ex vivo using herpes
simplex virus amplicons encoding 4-1BBL persist in the host and
show antitumor activity in vivoCancer
Res671002710037200710.1158/0008-5472.CAN-06-2391
|
13.
|
Y KuangX WengX LiuH ZhuZ ChenB JiangH
ChenAnti-tumor immune response induced by dendritic cells
transduced with truncated PSMA IRES 4-1BBL recombinant
adenovirusesCancer
Lett293254262201010.1016/j.canlet.2010.01.01120149524
|
14.
|
KA Shafer-WeaverSK WatkinsMJ AndersonLJ
DraperA MalyguineWG AlvordNM GreenbergAA HurwitzImmunity to murine
prostatic tumors: continuous provision of T-cell help prevents CD8
T-cell tolerance and activates tumor-infiltrating dendritic
cellsCancer Res6962576264200919622771
|
15.
|
M Habib-AgahiTT PhanPF
SearleCo-stimulation with 4-1BB ligand allows extended T-cell
proliferation, synergizes with CD80/CD86 and can reactivate anergic
T cellsInt Immunol1913831394200710.1093/intimm/dxm10617977894
|
16.
|
S RadhakrishnanKR WiehagenV PulkoV Van
KeulenWA FaubionKL KnutsonLR PeaseInduction of a Th1 response from
Th2-polarized T cells by activated dendritic cells: dependence on
TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gammaJ
Immunol17835833592200710.4049/jimmunol.178.6.3583
|
17.
|
EL GautierT HubyF Saint-CharlesB
OuzilleauJ PiraultV DeswaerteF GinhouxER MillerJL WitztumMJ
ChapmanP LesnikConventional dendritic cells at the crossroads
between immunity and cholesterol homeostasis in
atherosclerosisCirculation11923672375200910.1161/CIRCULATIONAHA.108.80753719380622
|
18.
|
ML DrakesSJ CzinnTG BlanchardRegulation of
murine dendritic cell immune responses by Helicobacter felis
antigenInfect Immun7446244633200610.1128/IAI.00289-0616861650
|
19.
|
MR JenkinsJ MinternNL La GrutaK
KedzierskaPC DohertySJ TurnerCell cycle-related a quisition of
cytotoxic mediators defines the progressive differentiation to
effector status for virus specific CD8+ T cellsJ
Immunol18138183822200810.4049/jimmunol.181.6.381818768835
|
20.
|
RK SharmaKG ElpekES YolcuRH SchabowskyH
ZhaoL Bandura-MorganH ShirwanCostimulation as a platform for the
development of vaccines: a peptide-based vaccine containing a novel
form of 4-1BB ligand eradicates established tumorsCancer
Res6943194326200910.1158/0008-5472.CAN-08-314119435920
|
21.
|
T KurodaY KitadaiS TanakaX YangN MukaidaM
YoshiharaK ChayamaMonocyte chemoattractant protein-1 transfection
induces angiogenesis and tumorigenesis of gastric carcinoma in nude
mice via macrophage recruitmentClin Cancer
Res1176297636200510.1158/1078-0432.CCR-05-0798
|
22.
|
SJ XieQH YanBE ShanZX FuFJ MengBD LiJH
CaiIn vitro experimental study individualised immunotherapy induced
by dendritic cells transfected with total RNA of autologous gastric
cancer cellsXi Bao Yu Fen Zi Mian Yi Xue Za Zhi2292952006
|